Roger K. Cady
Corporate Officer/Principal bei ALDER BIOPHARMACEUTICALS, INC.
Profil
Roger K.
Cady is the founder of Primary Care Network, Inc. He is currently the Director of the National Headache Foundation and the Vice President-Neurology at Lundbeck Seattle BioPharmaceuticals, Inc. He was previously the Medical Director at Shealy Institute for Comprehensive Pain.
He received his undergraduate degree from Drake University and his doctorate from Mayo Medical School.
Aktive Positionen von Roger K. Cady
| Unternehmen | Position | Beginn |
|---|---|---|
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 06.06.2016 |
| National Headache Foundation | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Roger K. Cady
| Unternehmen | Position | Ende |
|---|---|---|
Shealy Institute for Comprehensive Pain
 Shealy Institute for Comprehensive Pain Medical/Nursing ServicesHealth Services Part of Cluster Technology Corp., Shealy Institute for Comprehensive Pain is a medical clinic for pain management. The company is based in Springfield, MO. Shealy Institute for Comprehensive Pain was acquired by Cluster Technology Corp. on January 21, 1998. | Technik-/Wissenschafts-/F&E-Leiter | - |
Primary Care Network, Inc.
 Primary Care Network, Inc. Medical/Nursing ServicesHealth Services Primary Care Network, Inc. provides health care services. The company is headquartered in Springfield, MO. | Gründer | - |
Ausbildung von Roger K. Cady
| Drake University | Undergraduate Degree |
| Mayo Medical School | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Primary Care Network, Inc.
Primary Care Network, Inc. Medical/Nursing ServicesHealth Services Primary Care Network, Inc. provides health care services. The company is headquartered in Springfield, MO. | Health Services |
Shealy Institute for Comprehensive Pain
Shealy Institute for Comprehensive Pain Medical/Nursing ServicesHealth Services Part of Cluster Technology Corp., Shealy Institute for Comprehensive Pain is a medical clinic for pain management. The company is based in Springfield, MO. Shealy Institute for Comprehensive Pain was acquired by Cluster Technology Corp. on January 21, 1998. | Health Services |
| National Headache Foundation |
